Augmented ?2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size.
Ontology highlight
ABSTRACT: BACKGROUND:Ischemic stroke provokes a neuroinflammatory response and simultaneously promotes release of epinephrine and norepinephrine by the sympathetic nervous system. This increased sympathetic outflow can act on ?2-adrenergic receptors expressed by immune cells such as brain-resident microglia and monocyte-derived macrophages (MDMs), but the effect on post-stroke neuroinflammation is unknown. Thus, we investigated how changes in ?2-adrenergic signaling after stroke onset influence the microglia/MDM stroke response, and the specific importance of microglia/MDM ?2-adrenergic receptors to post-stroke neuroinflammation. METHODS:To investigate the effects of ?2-adrenergic receptor manipulation on post-stroke neuroinflammation, we administered the ?2-adrenergic receptor agonist clenbuterol to mice 3?h after the onset of photothrombotic stroke. We immunostained to quantify microglia/MDM numbers and proliferation and to assess morphology and activation 3?days later. We assessed stroke outcomes by measuring infarct volume and functional motor recovery and analyzed gene expression levels of neuroinflammatory molecules. Finally, we evaluated changes in cytokine expression and microglia/MDM response in brains of mice with selective knockout of the ?2-adrenergic receptor from microglia and monocyte-lineage cells. RESULTS:We report that clenbuterol treatment after stroke onset causes enlarged microglia/MDMs and impairs their proliferation, resulting in reduced numbers of these cells in the peri-infarct cortex by 1.7-fold at 3?days after stroke. These changes in microglia/MDMs were associated with increased infarct volume in clenbuterol-treated animals. In mice that had the ?2-adrenergic receptor specifically knocked out of microglia/MDMs, there was no change in morphology or numbers of these cells after stroke. However, knockdown of ?2-adrenergic receptors in microglia and MDMs resulted in increased expression of TNF? and IL-10 in peri-infarct tissue, while stimulation of ?2-adrenergic receptors with clenbuterol had the opposite effect, suppressing TNF? and IL-10 expression. CONCLUSIONS:We identified ?2-adrenergic receptor signaling as an important regulator of the neuroimmune response after ischemic stroke. Increased ?2-adrenergic signaling after stroke onset generally suppressed the microglia/MDM response, reducing upregulation of both pro- and anti-inflammatory cytokines, and increasing stroke size. In contrast, diminished ?2-adrenergic signaling in microglia/MDMs augmented both pro- and anti-inflammatory cytokine expression after stroke. The ?2-adrenergic receptor may therefore present a therapeutic target for improving the post-stroke neuroinflammatory and repair process.
SUBMITTER: Lechtenberg KJ
PROVIDER: S-EPMC6540436 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA